• CMA drops anti-competitive case against MSD pharmatimes
    March 19, 2019
    The Competition and Markets Authority (CMA) has closed its investigation into a suspected anti-competitive discount scheme developed by Merck Sharp & Dohme (MSD) after finding no grounds for action.
PharmaSources Customer Service